Azenta Inc (NASDAQ:AZTA) Reports Mixed Q3 2025 Earnings: Revenue Miss but EPS Beat

Azenta Inc (NASDAQ:AZTA) reported its third-quarter fiscal 2025 earnings, delivering mixed results relative to analyst expectations. The life sciences solutions provider posted revenue of $143.94 million, falling short of the consensus estimate of $152.41 million. However, the company outperformed on earnings per share (EPS), reporting $0.19 compared to the estimated $0.14.

Key Takeaways from the Earnings Report

• Revenue Miss: Azenta’s Q3 revenue came in approximately 5.5% below expectations, signaling potential challenges in sales execution or demand fluctuations in its sample management and multiomics segments.
• EPS Beat: Despite the revenue shortfall, the company managed to deliver higher-than-expected profitability, suggesting improved cost controls or favorable margin dynamics.
• Full-Year Guidance Reiterated: Azenta maintained its fiscal 2025 outlook, indicating confidence in hitting its annual targets despite the quarterly revenue miss.

Market Reaction

The stock saw a modest pre-market decline of about 0.93%, reflecting investor caution following the revenue miss. Over the past month, shares have been relatively flat, with a slight gain of 3.1%, while weekly performance dipped by 5%. The muted reaction may indicate that investors are weighing the EPS beat against the softer revenue figure, with the reiterated guidance providing some stability.

Looking Ahead

Analysts expect Azenta to generate $159.13 million in revenue for Q4 2025, with full-year sales projected at $608.41 million. The company’s ability to meet or exceed these estimates will likely hinge on execution in its core segments, particularly as demand for genomic services and cold-chain sample management continues to evolve.

For a deeper dive into Azenta’s earnings history and future estimates, visit the earnings and estimates page.

Disclaimer: This article is not investment advice. Investors should conduct their own research or consult a financial advisor before making decisions.